Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

HIV prevention was allocated A$43.9 million over three years in this week's federal budget. Some $26m of this is for "PrEP" for people without access to Medicare. PrEP means pre-exposure ...

On National HIV Testing Day, getting tested remains a gateway to prevention and treatment, but improving access alone is not enough. Expanding access to PrEP, PEP, pharmacists, long-acting therapies, ...

A pilot study found that a two-page decision aid increased awareness of a little-known injectable and allowed patients to ...

Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high risk for infection, according to an interim analysis of the phase 3 PURPOSE ...

The US Preventive Services Task Force (USPSTF) announced its recommendation for HIV pre-exposure prophylaxis (PrEP). The US Preventive Services Task Force (USPSTF) granted an “A” grade for HIV ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...

Advocacy groups called out CVS Health's August decision to not include Yeztugo in its formularies in a Sept. 18 letter. (Photo by Justin Sullivan/Getty Images) The Centers for Disease Control and ...

Gilead Sciences looks to launch Sunlenca in the pre-exposure prophylaxis market as a long-acting option in 2025. (Photo by Justin Sullivan/Getty Images) With Gilead Sciences' stated focus to grow in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...